Skip to main content
. Author manuscript; available in PMC: 2018 Jan 21.
Published in final edited form as: Phys Med Biol. 2016 Dec 20;62(2):394–414. doi: 10.1088/1361-6560/62/2/394

Figure 2.

Figure 2

In the current study, the targeted imaging agent was fluorescently labeled epidermal growth factor (IRDye® 800CW EGF) and the control imaging agent was an unbound fluorescent molecular (IRDye® 700DX Carboxylate). Temporal kinetics of both imaging agents were measured in surgically exposed subcutaneous xenograft tumors grown in severe combined immunodeficiency (SCID) mice using a dual-channel fluorescent scanner (Odyssey® Imaging System, LI-COR Biosciences) at 2–5-min intervals up to 60 min post-agent-injection.